Company
Strados Labs
The Full Endpoint Spectrum. One Partner.
- Business model
- B2B
- Customers
- sponsors and CROs
- Legal name
- Strados Labs, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Strados combines continuous monitoring, advanced AI algorithms, and expert human review to deliver regulatory-grade respiratory endpoint data. Our intelligence advantage ensures every measurement meets the rigorous standards required for clinical trials.
Funding snapshot
- Total raised
- $5.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $585K2022-05-20
Funding rounds
- Round, 2022
- $585K2022-05-20, SEC form D sold, 12 investors
- Round, 2021
- $3.1M2021-07-22, SEC form D sold, 29 investors
- Round, 2020
- $250K2020-05-14, SEC form D sold, 1 investor
- Round, 2019
- $1.9M2019-04-25, SEC form D sold, 16 investors
Products
- Web
- Air Next Spirometer
- Web
- eCOA
- Web
- NObreath FeNO
- Web
- RESP Biosensor
- Web
- RESP Watch
Loading relationship preview